Cargando…

Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer Disease

Individuals with Alzheimer Disease who develop psychotic symptoms (AD + P) experience more rapid cognitive decline and have reduced indices of synaptic integrity relative to those without psychosis (AD-P). We sought to determine whether the postsynaptic density (PSD) proteome is altered in AD + P re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krivinko, J. M., DeChellis-Marks, M. R., Zeng, L., Fan, P., Lopez, O. L., Ding, Y., Wang, L., Kofler, J., MacDonald, M. L., Sweet, R. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238472/ https://www.ncbi.nlm.nih.gov/pubmed/37268664 http://dx.doi.org/10.1038/s42003-023-04961-5

Ejemplares similares

Psychosis in Alzheimer's Disease Is Associated With Increased Excitatory Neuron Vulnerability and Post-transcriptional Mechanisms Altering Synaptic Protein Levels
por: DeChellis-Marks, Michael R., et al.
Publicado: (2022)

Fingolimod mitigates synaptic deficits and psychosis‐like behavior in APP/PSEN1 mice
por: Krivinko, Josh M., et al.
Publicado: (2022)

Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease
por: Fan, Peihao, et al.
Publicado: (2023)

Superior Cluneal Neuralgia Treated With Wireless Peripheral Nerve Stimulation
por: Chauhan, Gaurav, et al.
Publicado: (2022)

Genetic Risk for Schizophrenia and Psychosis in Alzheimer Disease
por: DeMichele-Sweet, Mary Ann A., et al.
Publicado: (2017)

Psychosis in Alzheimer’s Disease
por: Ballard, Clive, et al.
Publicado: (2020)

Genome-wide copy-number variation study of psychosis in Alzheimer's disease
por: Zheng, X, et al.
Publicado: (2015)

Psychosis in Alzheimer's Disease in the National Alzheimer's Disease Coordinating Center Uniform Data Set: Clinical Correlates and Association with Apolipoprotein E
por: DeMichele-Sweet, Mary Ann A., et al.
Publicado: (2011)

Lipodystrophy, Diabetes and Normal Serum Insulin in PPARγ-Deficient Neonatal Mice
por: O’Donnell, Peter E., et al.
Publicado: (2016)

Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype
por: Hesse, Raphael, et al.
Publicado: (2019)

G protein βγ subunits play a critical role in the actions of amphetamine
por: Mauna, J. C., et al.
Publicado: (2019)

Quantitative Proteomics of Synaptic and Nonsynaptic Mitochondria: Insights for Synaptic Mitochondrial Vulnerability
por: Stauch, Kelly L., et al.
Publicado: (2014)

Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype
por: Christie, Drew, et al.
Publicado: (2012)

Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer’s disease
por: Stepler, Kaitlyn E., et al.
Publicado: (2020)

A Rare Duplication on Chromosome 16p11.2 Is Identified in Patients with Psychosis in Alzheimer's Disease
por: Zheng, Xiaojing, et al.
Publicado: (2014)

VSNL1 Co-Expression Networks in Aging Include Calcium Signaling, Synaptic Plasticity, and Alzheimer’s Disease Pathways
por: Lin, Chien-Wei, et al.
Publicado: (2015)

Experience-Induced Remodeling of the Hippocampal Post-synaptic Proteome and Phosphoproteome
por: Heo, Seok, et al.
Publicado: (2023)

Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction
por: Petrov, A. M., et al.
Publicado: (2017)

An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
por: Kempf, Stefan J., et al.
Publicado: (2016)

3D Analysis of the Synaptic Organization in the Entorhinal Cortex in Alzheimer’s Disease
por: Domínguez-Álvaro, M., et al.
Publicado: (2021)

Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research
por: Grubisha, Melanie J., et al.
Publicado: (2021)

Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder
por: Föcking, M, et al.
Publicado: (2016)

TNFα affects CREB-mediated neuroprotective signaling pathways of synaptic plasticity in neurons as revealed by proteomics and phospho-proteomics
por: Jensen, Pia, et al.
Publicado: (2017)

c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
por: Sclip, A, et al.
Publicado: (2014)

Proteomic profiling of neuronal mitochondria reveals modulators of synaptic architecture
por: Graham, Laura C., et al.
Publicado: (2017)

Network Systems Pharmacology-Based Mechanism Study on the Beneficial Effects of Vitamin D against Psychosis in Alzheimer’s Disease
por: Fan, Peihao, et al.
Publicado: (2020)

Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease
por: DeMichele-Sweet, Mary Ann A., et al.
Publicado: (2021)

Increased retention of tau PET ligand [(18)F]-AV1451 in Alzheimer’s Disease Psychosis
por: Gomar, J. J., et al.
Publicado: (2022)

Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brain
por: Lorenz-Guertin, Joshua M., et al.
Publicado: (2023)

Cell-type and subcellular compartment-specific APEX2 proximity labeling reveals activity-dependent nuclear proteome dynamics in the striatum
por: Dumrongprechachan, V., et al.
Publicado: (2021)

Social Dysfunction and Diet Outcomes in People with Psychosis
por: Mucheru, Doreen, et al.
Publicado: (2017)

Has cognitive behavioural therapy for psychosis been oversold?
por: McKenna, Peter, et al.
Publicado: (2014)

Impaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity
por: Ranlund, Siri, et al.
Publicado: (2015)

The proteomic landscape of synaptic diversity across brain regions and cell types
por: van Oostrum, Marc, et al.
Publicado: (2023)

Aging synaptic mitochondria exhibit dynamic proteomic changes while maintaining bioenergetic function
por: Stauch, Kelly L., et al.
Publicado: (2014)

CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis
por: Huang, Jeffrey T.-J., et al.
Publicado: (2007)

Psychosis as alzheimer disease debut: a case report
por: Vilella Martín, C., et al.
Publicado: (2022)

Parasites, proteomes and systems: has Descartes’ clock run out of time?
por: WASTLING, J. M., et al.
Publicado: (2012)

Dynamic proteomic and phosphoproteomic atlas of corticostriatal axons in neurodevelopment
por: Dumrongprechachan, Vasin, et al.
Publicado: (2022)

Alzheimer's disease: synaptic dysfunction and Aβ
por: Shankar, Ganesh M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_thitt5i417ik45qtg5b9n6lfmh